In vivo phosphorus NMR studies of the hepatic metabolism of amino sugars.

[1]  D. Keppler,et al.  Dual role of hexose-1-phosphate uridylyltransferase in galactosamine metabolism. , 2005, European journal of biochemistry.

[2]  R. London,et al.  NMR observability of ATP: preferential depletion of cytosolic ATP during ischemia in perfused rat liver. , 1988, Biochemistry.

[3]  R. London,et al.  In vivo 31P NMR studies of the hepatic response to L-ethionine in anesthetized rats. , 1987, Toxicology and applied pharmacology.

[4]  J. Griffiths,et al.  Phosphorylation status of liver by 31P-n.m.r. spectroscopy, and its implications for metabolic control. A comparison of 31P-n.m.r. spectroscopy (in vivo and in vitro) with chemical and enzymic determinations of ATP, ADP and Pi. , 1985, The Biochemical journal.

[5]  M. Thompson,et al.  An approach to NMR studies of the metabolism of internal organs using surface coils. , 1985, Journal of biochemical and biophysical methods.

[6]  B. Ross,et al.  Formation of n.m.r.-invisible ADP during renal ischaemia in rats. , 1984, The Biochemical journal.

[7]  G. Matson,et al.  Longitudinal (T1) relaxation times of phosphorus metabolites in the bovine and rabbit lens. , 1984, Experimental eye research.

[8]  D. Gadian,et al.  Mapping of metabolites in whole animals by 31P NMR using surface coils , 1980, Nature.

[9]  K. Decker,et al.  Differential response of ATP and orthophosphate in cytosol and mitochondria of rat hepatocytes to treatment with Pi and d‐galactosamine , 1978, FEBS letters.

[10]  R G Shulman,et al.  31P nuclear magnetic resonance studies of bioenergetics and glycolysis in anaerobic Escherichia coli cells. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Sato,et al.  Studies on the metabolism of hexosamine. A kinase activity for D-glucosamine without inhibition by glucose in rat liver and its possible identity with glucokinase. , 1977, Journal of Biochemistry (Tokyo).

[12]  R. Winzler,et al.  Inhibitory effect of d-glucosamine and other sugar analogs on the viability and transplantability of ascites tumor cells. , 1969, Cancer research.

[13]  D. G. Walker,et al.  Some properties of galactokinase in developing rat liver. , 1968, The Biochemical journal.

[14]  E. Farber,et al.  On the mechanism of induction of hepatic adenosine triphosphate deficiency by ethionine. , 1966, The Journal of biological chemistry.

[15]  J. H. Quastel,et al.  Inhibition of Tumour Growth by D-Glucosamine , 1953, Nature.

[16]  D. Keppler,et al.  Potentiation of antimetabolite action by uridylate trapping. , 1985, Advances in enzyme regulation.

[17]  A. N. Stevens,et al.  NMR Studies of metabolites in living tissue , 1982 .

[18]  D. Keppler,et al.  Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. , 1974, Reviews of physiology, biochemistry and pharmacology.

[19]  D. Keppler,et al.  Galactosamine induced liver injury. , 1972, Progress in liver diseases.

[20]  F. Ballard.  Purification and properties of galactokinase from pig liver. , 1966, The Biochemical journal.